Back to Search
DANIELLE HELBLING, PHARMD
PHARMD
Pharmacist
NPI: 1043935463Individual
Specialties, Licenses & Credentials
PharmacistPrimary
Pharmacist
Code: 183500000X
RP448892(PA)
Research & Publications (8)
Continuous monitoring of residual chlorine concentrations in response to controlled microbial intrusions in a laboratory-scale distribution system.
PMID 18433828·Water Res·2008
8-other
CBFB-SMMHC is correlated with increased calreticulin expression and suppresses the granulocytic differentiation factor CEBPA in AML with inv(16).
PMID 15855281·Blood·2005
8-other
Disseminated cytomegalovirus infection in Crohn's disease following anti-tumour necrosis factor therapy.
PMID 12468964·Eur J Gastroenterol Hepatol·2002
5-case
Spinal segmental stabilisation exercises for chronic low back pain: programme adherence and its influence on clinical outcome.
PMID 19609785·Eur Spine J·2009
8-other
Adding cetuximab to capecitabine plus oxaliplatin (XELOX) in first-line treatment of metastatic colorectal cancer: a randomized phase II trial of the Swiss Group for Clinical Cancer Research SAKK.
PMID 18349029·Ann Oncol·2008
3-trial
Successful challenge with the fully human EGFR antibody panitumumab following an infusion reaction with the chimeric EGFR antibody cetuximab.
PMID 17488734·Ann Oncol·2007
5-case
The leukemic fusion gene AML1-MDS1-EVI1 suppresses CEBPA in acute myeloid leukemia by activation of Calreticulin.
PMID 15326310·Proc Natl Acad Sci U S A·2004
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1003 CALIFRONIA AVENUE
NATRONA HEIGHTS, PA 15065 - Phone
- (724) 224-9084
Quick Facts
- NPI
- 1043935463
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 8
Are you this provider?
Claim Your Profile